Free Newsletter
NIH readies new guidelines on stem cell research
For years stem cell researchers have complained that federal guidelines limited the number of embryonic stem cell lines they could work with to a tiny selection. But all of that is about to change.
In new draft rules developed by the NIH, the government is preparing to approve funding for projects that use cell lines derived from discarded embryos at fertility clinics. And the Obama administration is moving quickly to live up to a campaign pledge to broaden federal support for stem cell research.
"We will expand greatly the number of cell lines eligible for funding," said Raynard Kington, acting NIH director. "We know of several hundred cell lines that will meet the guideline standards."
As the Wall Street Journal notes, though, there are some restrictions being left in place that could pose road blocks to researchers. Federal money will not be offered to researchers working with cell lines derived from cloned embryos, embryos created just for research purposes or through parthogenesis. But Kington says the NIH will keep its mind open as it continues to review the field in coming years.
- check out the report in the Wall Street Journal
Related Articles:
NIH creates new stem cell research center
Research advocates call for big hike in NIH grants
US stem cell research ready to leap ahead
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




